FDA-Drug2018-12-26Class II
Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Inc. New York, NY 10017, NDC 60793-855-01
Pfizer Inc.
Hazard
Superpotent Drug.
Sold states
Nationwide within the United States
Affected count
1996 bottles
Manufactured in
235 E 42nd St, New York, NY, United States
Products
Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Inc. New York, NY 10017, NDC 60793-855-01
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0339-2019Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief